BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Treatment
499 results:

  • 1. IL-12-Overexpressed Nanoparticles Suppress the Proliferation of Melanoma Through Inducing ICD and Activating DC, CD8
    Shen HH; Peng JF; Wang RR; Wang PY; Zhang JX; Sun HF; Liang Y; Li YM; Xue JN; Li YJ; Sun GB; Xie SY
    Int J Nanomedicine; 2024; 19():2755-2772. PubMed ID: 38525008
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [MACULOPAPULAR CUTANEOUS MASTOCYTOSIS HARBORING A kit MUTATION (ASP419DEL): A CASE REPORT].
    Fukaura A; Numata T; Chiyotanda M; Maeda T; Egusa C; Ito T; Harada K; Okubo Y
    Arerugi; 2024; 73(2):189-195. PubMed ID: 38522933
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of immunological patterns characterizing immune-related psoriasis reactions in oncological patients in therapy with anti-PD-1 checkpoint inhibitors.
    Morelli M; Carbone ML; Scaglione GL; Scarponi C; Di Francesco V; Pallotta S; De Galitiis F; Rahimi S; Madonna S; Failla CM; Albanesi C
    Front Immunol; 2024; 15():1346687. PubMed ID: 38495872
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances.
    Kim HJ; Kim YH
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474231
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nilotinib in kit-driven advanced melanoma: Results from the phase II single-arm NICAM trial.
    Larkin J; Marais R; Porta N; Gonzalez de Castro D; Parsons L; Messiou C; Stamp G; Thompson L; Edmonds K; Sarker S; Banerji J; Lorigan P; Evans TRJ; Corrie P; Marshall E; Middleton MR; Nathan P; Nicholson S; Ottensmeier C; Plummer R; Bliss J; Valpione S; Turajlic S
    Cell Rep Med; 2024 Mar; 5(3):101435. PubMed ID: 38417447
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression.
    Bai X; Li S; Luo Y
    Int Ophthalmol; 2024 Feb; 44(1):55. PubMed ID: 38342795
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Water-soluble intracellular extract of Desmodesmus sp. YT enhanced the antioxidant capacity of human skin fibroblast to protect the skin from UV damage.
    Ying M; Zeng Z; Li Q; Chen X; Xiong Y; Wu B; Peng L; Zhang Q; Wang L; Dai Z; Li S; Chen H; Yang X
    J Cosmet Dermatol; 2024 May; 23(5):1850-1861. PubMed ID: 38327116
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evodiamine inhibits growth of vemurafenib drug-resistant melanoma via suppressing IRS4/PI3K/AKT signaling pathway.
    Guo X; Huang S; Zhang Y; Wang H; Li L; Ran J; Chen D; Li X; Li J
    J Nat Med; 2024 Mar; 78(2):342-354. PubMed ID: 38324123
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The promotive role of lncRNA MIR205HG in proliferation, invasion, and migration of melanoma cells via the JMJD2C/ALKBH5 axis.
    Liu Y; Wang S; Wei S; Qiu X; Mei Y; Yan L
    PLoS One; 2024; 19(1):e0290986. PubMed ID: 38252669
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mastocytosis in the skin in dogs: A multicentric case series.
    Wyatt EK; Affolter V; Borio S; Guillen A; Verganti S; Murphy S; Ballarini D; Banovic F; Schmidt V; Tanis JB
    Vet Comp Oncol; 2024 Mar; 22(1):136-148. PubMed ID: 38243867
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma.
    Dedeilia A; Lwin T; Li S; Tarantino G; Tunsiricharoengul S; Lawless A; Sharova T; Liu D; Boland GM; Cohen S
    Ann Surg Oncol; 2024 Apr; 31(4):2713-2726. PubMed ID: 38158497
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
    Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
    Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Phytochemically analysed extract of Ageratina adenophora (Sprengel) R.M.King & H. Rob. initiates caspase 3-dependant apoptosis in colorectal cancer cell: A synergistic approach with chemotherapeutic drugs.
    Chanu KD; Thoithoisana S; Kar A; Mukherjee PK; Radhakrishnanand P; Parmar K; Sharma N
    J Ethnopharmacol; 2024 Mar; 322():117591. PubMed ID: 38104872
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. STING promotes invasion and migration of uveal melanoma through p38‑MAPK signaling.
    Zhou X; Meng F; Xu B; Ma R; Cheng Y; Wu J; Qian J
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099424
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. treatment of acral and mucosal melanoma: Current and emerging targeted therapies.
    Zhang J; Tian H; Mao L; Si L
    Crit Rev Oncol Hematol; 2024 Jan; 193():104221. PubMed ID: 38036156
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. When Mast Cells Run Amok: A Comprehensive Review and Case Study on Severe Neonatal Diffuse Cutaneous Mastocytosis.
    Olteanu EG; Bataneant M; Puiu M; Chirita-Emandi A
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002964
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Efficacy of adjuvant programmed cell death 1 (PD-1) monoclonal antibody immunotherapy in Chinese patients with resected stage Ⅱ-Ⅲ melanoma].
    Ren ZG; Xu Y; Hua ZZ; Mo ZY; Wang LW; Shi GB; Liu WL; Sun W; Zheng BQ; Wang CM; Jin YJ; Chen Y
    Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):973-980. PubMed ID: 37968084
    [No Abstract]    [Full Text] [Related]  

  • 18. In vitro evaluation of Neosetophomone B inducing apoptosis in cutaneous T cell lymphoma by targeting the FOXM1 signaling pathway.
    Kuttikrishnan S; Masoodi T; Ahmad F; Sher G; Prabhu KS; Mateo JM; Buddenkotte J; El-Elimat T; Oberlies NH; Pearce CJ; Bhat AA; Alali FQ; Steinhoff M; Uddin S
    J Dermatol Sci; 2023 Nov; 112(2):83-91. PubMed ID: 37865581
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Rare malignant neoplasm of the esophagus: current status and future perspectives.
    Yoshinami Y; Nishimura E; Hosokai T; Yamamoto S; Matsuda S; Nomura M; Kawakubo H; Kato K; Kitagawa Y
    Jpn J Clin Oncol; 2024 Feb; 54(2):111-120. PubMed ID: 37861097
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
    Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
    Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 25.